236 related articles for article (PubMed ID: 17711510)
1. Increased expression of transient receptor potential vanilloid subfamily 1 in the bladder predicts the response to intravesical instillations of resiniferatoxin in patients with refractory idiopathic detrusor overactivity.
Liu HT; Kuo HC
BJU Int; 2007 Nov; 100(5):1086-90. PubMed ID: 17711510
[TBL] [Abstract][Full Text] [Related]
2. The molecular basis of urgency: regional difference of vanilloid receptor expression in the human urinary bladder.
Liu L; Mansfield KJ; Kristiana I; Vaux KJ; Millard RJ; Burcher E
Neurourol Urodyn; 2007; 26(3):433-8; discussion 439; discussion 451-3. PubMed ID: 17016800
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions.
Kuo HC
J Urol; 2003 Sep; 170(3):835-9. PubMed ID: 12913711
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of M2 and M3 muscarinic receptor expression in bladder from women with refractory idiopathic detrusor overactivity.
Mansfield KJ; Liu L; Moore KH; Vaux KJ; Millard RJ; Burcher E
BJU Int; 2007 Jun; 99(6):1433-8. PubMed ID: 17428242
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of multiple resiniferatoxin intravesical instillations in patients with refractory detrusor overactivity: a randomized, double-blind, placebo controlled study.
Kuo HC; Liu HT; Yang WC
J Urol; 2006 Aug; 176(2):641-5. PubMed ID: 16813911
[TBL] [Abstract][Full Text] [Related]
6. Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment.
Brady CM; Apostolidis AN; Harper M; Yiangou Y; Beckett A; Jacques TS; Freeman A; Scaravilli F; Fowler CJ; Anand P
BJU Int; 2004 Apr; 93(6):770-6. PubMed ID: 15049988
[TBL] [Abstract][Full Text] [Related]
7. Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin.
Apostolidis A; Brady CM; Yiangou Y; Davis J; Fowler CJ; Anand P
Urology; 2005 Feb; 65(2):400-5. PubMed ID: 15708075
[TBL] [Abstract][Full Text] [Related]
8. Effect of intravesical Resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation.
Apostolidis A; Gonzales GE; Fowler CJ
Eur Urol; 2006 Dec; 50(6):1299-305. PubMed ID: 16697519
[TBL] [Abstract][Full Text] [Related]
9. Multiple intravesical instillation of low-dose resiniferatoxin is effective in the treatment of detrusor overactivity refractory to anticholinergics.
Kuo HC
BJU Int; 2005 May; 95(7):1023-7. PubMed ID: 15839924
[TBL] [Abstract][Full Text] [Related]
10. Effect of botulinum toxin on expression of nerve growth factor and transient receptor potential vanilloid 1 in urothelium and detrusor muscle of rats with bladder outlet obstruction-induced detrusor overactivity.
Ha US; Park EY; Kim JC
Urology; 2011 Sep; 78(3):721.e1-721.e6. PubMed ID: 21782224
[TBL] [Abstract][Full Text] [Related]
11. Autonomous contractile activity in the isolated rat bladder is modulated by a TRPV1 dependent mechanism.
Gevaert T; Vandepitte J; Ost D; Nilius B; De Ridder D
Neurourol Urodyn; 2007; 26(3):424-32; discussion 451-3. PubMed ID: 17004230
[TBL] [Abstract][Full Text] [Related]
12. Intravesical resiniferatoxin for the treatment of women with idiopathic detrusor overactivity and urgency incontinence: A single dose, 4 weeks, double-blind, randomized, placebo controlled trial.
Rios LA; Panhoca R; Mattos D; Srugi M; Bruschini H
Neurourol Urodyn; 2007; 26(6):773-8. PubMed ID: 17638305
[TBL] [Abstract][Full Text] [Related]
13. Bladder base/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinics.
Kuo HC
Neurourol Urodyn; 2011 Sep; 30(7):1242-8. PubMed ID: 21560152
[TBL] [Abstract][Full Text] [Related]
14. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection.
Liu HT; Chancellor MB; Kuo HC
Eur Urol; 2009 Oct; 56(4):700-6. PubMed ID: 18472208
[TBL] [Abstract][Full Text] [Related]
15. Gosha-jinki-gan reduces transmitter proteins and sensory receptors associated with C fiber activation induced by acetic acid in rat urinary bladder.
Imamura T; Ishizuka O; Aizawa N; Zhong C; Ogawa T; Nakayama T; Tanabe T; Nishizawa O
Neurourol Urodyn; 2008; 27(8):832-7. PubMed ID: 18551569
[TBL] [Abstract][Full Text] [Related]
16. Modulation of urinary bladder innervation: TRPV1 and botulinum toxin A.
Charrua A; Avelino A; Cruz F
Handb Exp Pharmacol; 2011; (202):345-74. PubMed ID: 21290235
[TBL] [Abstract][Full Text] [Related]
17. Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder.
Liu HT; Chancellor MB; Kuo HC
BJU Int; 2009 Jun; 103(12):1668-72. PubMed ID: 19220267
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal delivery of resiniferatoxin (RTX) reduces detrusor overactivity and spinal expression of TRPV1 in spinal cord injured animals.
Cruz CD; Charrua A; Vieira E; Valente J; Avelino A; Cruz F
Exp Neurol; 2008 Dec; 214(2):301-8. PubMed ID: 18824169
[TBL] [Abstract][Full Text] [Related]
19. An extract (THC-002) of Ba-Wei-Die-Huang-Wan inhibits expression of tachykinins, and P2X3 and TRPV1 receptors, and inhibits ATP-induced detrusor overactivity in spontaneously hypertensive rats.
Imamura T; Ishizuka O; Zhong C; Ogawa T; Nakayama T; Kurizaki Y; Tanabe T; Nishizawa O; Andersson KE
Neurourol Urodyn; 2009; 28(6):529-34. PubMed ID: 19283865
[TBL] [Abstract][Full Text] [Related]
20. Effects of tolterodine on afferent neurotransmission in normal and resiniferatoxin treated conscious rats.
Hedlund P; Streng T; Lee T; Andersson KE
J Urol; 2007 Jul; 178(1):326-31. PubMed ID: 17507042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
